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The RlmA class of enzymes (RlmAI and RlmAII) catalyzes N1-methyl-
ation of a guanine base (G745 in Gram-negative and G748 in Gram-
positive bacteria) of hairpin 35 of 23S rRNA. We have determined the
crystal structure of Escherichia coli RlmAI at 2.8-Å resolution, provid-
ing 3D structure information for the RlmA class of RNA methyltrans-
ferases. The dimeric protein structure exhibits features that provide
new insights into its molecular function. Each RlmAI molecule has a
Zn-binding domain, responsible for specific recognition and binding
of its rRNA substrate, and a methyltransferase domain. The asym-
metric RlmAI dimer observed in the crystal structure has a well defined
W-shaped RNA-binding cleft. Two S-adenosyl-L-methionine substrate
molecules are located at the two valleys of the W-shaped RNA-
binding cleft. The unique shape of the RNA-binding cleft, different
from that of known RNA-binding proteins, is highly specific and
structurally complements the 3D structure of hairpin 35 of bacterial
23S rRNA. Apart from the hairpin 35, parts of hairpins 33 and 34 also
interact with the RlmAI dimer.
rrmA  methyltransferase  antibiotic resistance  RNA-binding protein
MLS (macrolide, lincosamide, streptogramin B) antibioticssuch as erythromycin, tylosin, and spiramycin are used in
treating bacterial infections in human and in animals (1). MLS
antibiotics bind to the large ribosomal subunit (2) and inhibit
translation, possibly by blocking the protein exit channel of the
ribosome (3–6). The effectiveness of MLS antibiotics is increasingly
limited by the emergence of resistant bacterial strains (1). Certain
modifications of bacterial rRNA are known to confer resistance to
MLS antibiotics (7, 8). One of the most common forms of bacterial
rRNA modification is nucleotide methylation (9); for example, 10
methylations of 16S rRNA and 14 methylations of 23S rRNA
nucleotides are reported (10) for Escherichia coli. Although most of
these modifications on rRNA occur before the formation of the
ribosomal complex (11), they primarily cluster around the catalytic
center of the ribosome (12). Methylated nucleotide G748 functions
synergistically with a methylated A2058 nucleotide to confer resis-
tance to certain MLS antibiotics (13, 14).
The N1-methylation of nucleotides G745 and G748 is carried out
by rRNA large subunit methyltransferases RlmAI and RlmAII
(formally known as rrmA and TlrB) enzymes, respectively (14).
RlmA enzymes are only present in bacteria (15). However, the
methyltransferase (MTase) domains of these enzymes exhibit
amino acid sequence similarity with functionally related enzymes
from eukaryotic and archea organisms and constitute a large,
structurally uncharacterized protein domain family (16). The RlmA
class I (RlmAI) enzyme is present in Gram-negative, and the RlmA
class II (RlmAII) enzyme is present in Gram-positive bacteria (17,
18). Comparison of the amino acid sequences of RlmAI and RlmAII
enzymes indicates that these enzyme classes are homologous (Fig.
1A); 29% of residues are conserved (18) across the species. Both
the RlmA classes (I and II) contain a conserved MTase domain and
use S-adenosyl-L-methionine (SAM) as the methyl group donor
(19). Despite functional similarity, RlmA enzymes from Gram-
positive bacteria have a characteristic difference from those of
Gram-negative bacteria: RlmAI methylates G745 (11, 17), whereas
RlmAII methylates G748 (20) at N1 position of the nucleotide bases.
Both of these nucleotides, G745 and G748, are located in hairpin
35 of 23S rRNA.
E. coli RlmAI is one of the best characterized RlmA enzymes
(17, 21–23). Modifications to nucleotides of rRNA hairpins 33,
34, and 35 affect methylation by RlmAI (11). A G745-deficient
E. coli strain (17) has shown slower growth rate as well as
increased resistance to ribosome-binding antibiotic viomycin,
which inhibits by blocking translation of peptidyl-tRNA. Here we
report the x-ray crystal structure of E. coli RlmAI at 2.8-Å
resolution. In addition, we describe modeling of the RlmAI
rRNA complex aimed at understanding the specific recognition
of this rRNA fragment, and the mechanism of N1-methylation
of G745 and G748.
Materials and Methods
Cloning, Expression, and Purification. E. coli gene rrmA coding for
RlmAI (Northeast Structural Genomics Consortium Target ID
ER19; www.nesg.org) was cloned into a pET21 (Novagen) deriv-
ative, generating plasmid pER19–21. E. coli BL21 (DE3) pMGK,
a rare codon-enhanced strain, was transformed with pER19–21. A
single isolate was cultured in MJ9 (24) minimal media containing
selenomethionine (Se-Met) to produce Se-Met-labeled RlmAI
protein (25). Initial growth was carried out at 37°C until the OD600
of the culture reached 1.0. The incubation temperature was then
decreased to 17°C, and protein expression was induced by the
addition of isopropyl--D-thiogalactopyranoside at a final concen-
tration of 1 mM. After overnight incubation at 17°C, the cells were
harvested by centrifugation.
C terminus LEHHHHHH-tagged Se-Met RlmAI was purified by
standard methods. Cell pellets were resuspended in lysis buffer (50
mM NaH2PO4, pH 8.0300 mM NaCl10 mM imidazole5 mM
2-mercaptoethanol) and disrupted by sonication. The resulting
lysate was clarified by centrifugation at 26,000 g for 45 min at 4°C.
The supernatant was loaded onto a nickel-nitrilotriacetic acid
column (Qiagen, Valencia, CA) and eluted in lysis buffer contain-
ing 250 mM imidazole. Fractions containing the partially purified
RlmAI were pooled and loaded onto a gel filtration column
(Superdex 75, Amersham Pharmacia), and eluted in Buffer A (10
mM Tris, pH 7.55 mM DTT10 mM NaCl0.02% sodium azide).
Abbreviations: MTase, methyltransferase; RlmAI, RlmA class I; RlmAII, RmlA class II; SAM,
S-adenosyl-L-methionine; Se-Met, selenomethionine.
Data deposition: The atomic coordinates and structure factors for the Escherichia coli RlmAI
structure have been deposited in the Protein Data Bank, www.pdb.org (PDB ID code 1P91).
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The resulting purified RlmAI protein was buffer exchanged and
concentrated in 10 mM Tris, pH 7.55 mM DTT to 10 mgml.
Sample purity (97%) and molecular mass (31.5 kDa) were
verified by SDSPAGE and matrix-assisted laser desorption ion-
ization time-of-flight (MALDI-TOF) mass spectrometry, respec-
tively. The yield of purified protein was 100 mg per 1 liter of
bacterial culture.
Crystallization. A sample of RlmAI at a concentration of 1.0
mgml in 10 mM TrisHCl was used for dynamic light scattering
measurements using a Protein Solutions DynaPro light-scattering
device. Radius of the sample based on 25 consecutive readings was
344 Å with a polydispersity of 43% (a standard value for most
crystallizing proteins is 25%). The calculated average molecular
mass of the large RlmAI aggregates observed in these measure-
ments (radius334 Å) is1.33 104 kDa, whereas the molecular
mass of an RlmAI monomer is 31.5 kDa.
Crystallization conditions for the RlmAI protein were surveyed
by using hanging drop vapor diffusion techniques and the Hampton
Crystal Screen I and II and PEGION screen kits. Initial trials with
protein concentrations of 10 mgml did not give any positive
indications of crystals, and most of the drops precipitated. Use of
a lower concentration of protein (6 mgml) yielded fiber-like
micro crystals using Hampton Crystal Screen II no. 15 (0.5 M
ammonium sulfate1.0 M lithium sulfate0.1 M sodium citrate, pH
6.5). After numerous optimization attempts, the hanging drop setup
with 4 mgml protein in 10 mM TrisHCl, pH 7.55 mM SAM5
mM DTT produced the best crystals when vapor diffused against
the above crystallization solution. The crystals grew to optimum
size of 0.1  0.1  0.05 mm3 in 4 weeks at 22°C.
Data Collection and Structure Determination. Se-Met E. coli RlmAI
crystals were mounted on cryo-loops, cryoprotected by dipping in
solution containing 20% ethylene glycol, and flash-cooled in liquid
N2. Multiple anomalous diffraction (MAD) data were collected at
X12C NSLS, Brookhaven National Laboratory (BNL) from one
flash-cooled crystal. The data (Table 1) were processed to 3.2-Å
resolution by using DENZOSCALEPACK (26). Another crystal with
comparable dimensions was used to collect higher resolution data
at the F1 beam line of the Cornell High Energy Synchrotron Source
(CHESS), and processed at 2.8-Å resolution. Thirteen Se sites were
found by using the Direct Methods implemented in SNB 1.0 (27). The
phases were calculated at 3.5-Å resolution, by SOLVE 2.03 using the
Se sites, and extended to 3.2-Å resolution by using NCS averaging
and solvent correction methods implemented in RESOLVE (28). The
electron density calculated at 3.2-Å resolution was well defined, and
Fig. 1. (A) Amino acid sequence alignment (40) of selected RlmAI enzymes from Gram-negative (top six sequences) and RlmAII enzymes from Gram-positive
(bottom four sequences) bacteria. Conserved amino acids are in red. The secondary structure elements of E. coli RlmAI (RRMAECOLI) determined in this work
are mapped onto the alignment. (B) A ribbon diagram (41) of the E. coli RlmAI monomer structure. The three-strand small antiparallel -sheet, a part of the
Zn-binding domain, is in blue, and the eight-stranded mixed -sheet of the MTase domain is in cyan. The helices, except helix 5 (pink), are bundled into two
groups (orange and red). The only 310-helix in the structure (1) is colored blue. The SAM substrate (in yellow) is bound at the center of the MTase domain. (C)
A 2D representation of the fold of RlmAI. The color code of the secondary structure elements is the same as in B. The amino acid positions are numbered at the
beginning and end of the secondary structure elements.
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most of the amino acid residues could be modeled manually. Later,
2.8-Å resolution data were used to refine the structure. Cycles of
model building (using O; ref. 29) and refinement [initially by using
REFMAC V 5.1.24 (30) implemented in CCP4 V4.2.1, and later by using
CNS 1.1 (31)] augmented the experimental phases and allowed
identification of the remaining amino acid positions. The final
model was refined to R  0.248 and Rfree  0.296 (Table 1).
Results and Discussion
Overall Structure of RlmAI. The crystal structure of E. coli RlmAI is
shown in Fig. 1B, and a schematic representation of the arrange-
ment of the secondary structure elements is shown in Fig. 1C. The
structure was determined by Se-Met–MAD method and refined to
2.8-Å resolution. RlmAI crystallized as a dimer per asymmetric unit
(Fig. 2A), with dimensions 85  60  35 Å3. The two monomers
(each having molecular mass of 31.5 kDa and 2698 tag amino acid
residues) within the dimer have an unusual asymmetric arrange-
ment in which one monomer relates to the other by160° rotation
about a two-fold noncrystallographic symmetry axis. The dimer
contains a wide ‘‘W-shaped’’ cleft, a putative binding site for the
rRNA substrate. The rms deviation for superposition of C-atoms
of the two monomers is 1.1 Å.
The secondary structure of an RlmAI monomer includes eleven
-strands, eight -helices, and one 310-helix (Fig. 1 B and C). The
first three N-terminal -strands form a small antiparallel -sheet, a
part of a Zn-binding domain (Fig. 2B), and the remaining eight
strands form a large twisted mixed -sheet that contains a charac-
teristic MTase fold. An N-terminal Zn-binding domain (amino
acids 1–35) and a C-terminal MTase domain (amino acids 51–269)
are connected by a flexible linker of 12–15 aa. This linker is partially
ordered in molecule 1 and completely disordered in molecule 2 of
the crystallographic dimer. In the MTase domain, the two C-
terminal-strands10 and11 are curved and unusually long (50
Å in length), each containing 14–15 aa.
The base of the W-shaped RNA-binding cleft is formed by two
methyltransferase domains, one per monomer. Two valleys of the
W-shaped cleft contain two SAM molecules, one bound to each
monomer (Fig. 2A). The helices 6, 7, 8, and 1 (310-helix) as
well as parts of helices1 from each monomer are clustered to form
the RlmAI dimer interface. In addition to these interactions be-
tween RlmAI monomers, there are extensive interactions between
RlmAI dimeric units in the crystal structure. The large 10-strand
of molecule 1 interacts with the 10-strand of a crystallographic
symmetry related molecule 2 to form an extended 16-strand
-sheet. These two distinct sets of intermolecular interactions for
RlmAI molecules, (i) between the monomer units of the dimer and
(ii) between these dimers, as seen in the crystal structure, might also
exist in solution and could be responsible for formation of the large
aggregates (of average radius 344 Å) observed in dynamic light
scattering measurements.
Zn-Binding Domain. The N-terminal 35 amino acid residues of
RlmAI form a Zn-binding domain that appears to be important in
rRNA recognition. Within the Zn-binding domain, conserved
amino acids Cys-5, Cys-8, Cys-21, and His-25 coordinate with a
single Zn ion. The presence of Zn ion was evident from the
crystallographic study and was further confirmed by inductively
coupled plasmon resonance spectroscopy. The Zn-binding domain,
which is present in all members of both the RlmA enzyme classes
(Fig. 1A), has a novel Cys3His Zn-finger fold (Fig. 2B); its amino
acid consensus sequence (Cys-Pro-X-Cys-1213X-Cys-34X-His)
and 3D structure are different from those of previously character-
ized Zn-finger structures.
The two Zn ions, positioned at the two top edges of the W-shaped
RNA-binding cleft, are 32 Å apart; two highly conserved Cys-
Pro-Leu-Cys loops (amino acids 5–8, a part of the Zn-finger) are
24 Å apart. Based on rRNA docking (as discussed later), the
Cys-Pro-Leu-Cys loops and His-25 appear to be involved in recog-
nition and binding of the rRNA substrate, hairpin 35 region of 23S
rRNA. The Zn-binding domain of molecule 2 is less ordered, with
an average B factor of 82 Å2, compared with an average B factor
of 52 Å2 for the corresponding domain in molecule 1. The Zn-
binding domains, particularly of molecule 2, and the loops joining
them with the MTase domains may adjust their positions upon
interacting with the rRNA substrate and could consequently be
stabilized by RNAprotein interactions.
SAM Binding. RlmA enzymes use SAM as methyl group donor (19).
As mentioned above, SAM molecules are bound to the MTase
domains of both the RlmAI monomers (Fig. 2A). Difference
electron density maps clearly define the mode of binding of SAM
in the RlmAI enzyme structure (Fig. 2C). Relatively higher B
Table 1. Crystallographic parameters, x-ray data, and refinement statistics for E. coli RlmAI
Se-1 Se-2 Se-3 high resolution
Data collection facility BNL X12C BNL X12C BNL X12C CHESS F1
Wavelength (), Å 0.97889 0.97874 0.9500 0.9160
Resolution range, Å 50.0–3.2 50.0–3.2 50.0–3.2 50.0–2.8
Number of reflections (no. of observations) 28,604 (117,100) 28,528 (118,011) 28,354 (102,647) 21,876 (88,268)
Completeness 95.6 95.7 94.8 93.0
Average I(I) 4.7 3.7 4.2 11.0
Rmerge on I* 0.175 0.206 0.183 0.106
 cutoff I  1(I) I  1(I) I  1(I) I  0.5(I)
Mean figure of merit 0.40 (40.0–3.5 Å resolution)
Unit cell constants (space group) a  107.10, b  122.36, and c  142.68 Å (I222) a  107.19, b  122.28, c  143.14 Å
Data set used in structure refinement
Resolution range, Å 20–2.8 Å
Total number of reflections (Rfree set) 21,804 (1,138)
Completeness (Rfree set) 93% (5%)
Cutoff criteria Fo  1.0 (Fo)




Bond length, Å 0.012
Bond angle, ° 1.7
*Rmerge  hkliI(hkl)i  	I(hkl)
hkli	I(hkl)i
.
†Rcryst  hklFo(hkl)  kFc(hkl)hklFo(hkl), where Fo and Fc are observed and calculated structure factors, respectively.








factors of the SAM molecules, compared to those of the surround-
ing protein atoms, indicate partial occupancy (or positional disor-
der) of these substrate molecules. The amino acid residues that take
part in SAM binding, including Arg-58-Leu-62, Tyr-67, Leu-70,
Gly-93–Tyr-99, Ile-155–Tyr-156, His-183–Leu-184, and Met-233–
Pro-235 (Fig. 2C), are either identical or of similar types in
homologous RlmAI and RlmAII enzymes (Fig. 1A). Most of the
conserved amino acids interacting with the SAM molecule, except
those in 1 helices, are located on structurally flexible regions such
as polypeptide loops and the tips of helices pointing toward the
SAM-binding regions. The two SAM molecules, although bound in
similar regions of the monomers of RlmAI dimer, differ in their
precise orientations and specific interactions with protein atoms.
Presumably, binding of the RNA substrate is necessary for a SAM
molecule to bind to the RlmAI enzyme in a proper orientation for
MTase catalysis.
Comparison with Other rRNA Methyltransferase Structures. Crystal
structures of bacterial rRNA MTases E. coli RlmB (32), Bacillus
subtilis ErmC (33, 34), and Streptomyces viridochromogenes AviRa
(35) have been described. These enzymes are highly specific to their
respective RNA substrates, parts of bacterial rRNA. Although the
overall structures of these MTases are different, all three of these
enzymes contain MTase domains that have a common Rossmann-
type fold. The MTase domain of RlmAI also has this characteristic
fold. A Dali structural database search (36) identifies the MTase
domain of ErmC (33) as one of the top structural analogs (Z 
13.2; 140 C atoms superimposed with rms deviation of 1.8 Å) of
RlmAI. Despite the structural similarity of the SAM binding
MTase domains of RlmAI and ErmC (Fig. 3), the sequence
identity in the structurally superimposed regions is only 9%. Be-
cause of a low sequence identity with know structures, the fold of
the MTase domain of RlmA enzymes could not be recognized
before this structure determination.
A comparison of the overall structures of RlmAI and ErmC
provides some valuable insights (Fig. 3). The relative positions and
orientations of the bound SAM molecules in RlmAI differ signif-
icantly from those of the ErmC structure (33). In addition, the
putative rRNA-recognizing domains (e.g., the Zn-binding domain
of RlmAI) of the two enzymes have different tertiary fold and are
positioned differently with respect to superimposed MTase do-
mains (Fig. 3). This structure comparison suggests differences in the
mode of rRNA-substrate recognition by the MTase enzymes,
despite a plausible common catalytic mechanism. These structural
differences provide a basis for these enzymes’ specificities to their
respective substrates, different parts of bacterial rRNA. Among the
above discussed three rRNA MTase structures, the reported struc-
tures of ErmC (33) and AviRa (35) have no well defined RNA-
binding cleftpocket and the RNA-binding cleft that has been
Fig. 2. (A) Ribbon representation of an asymmetric dimer, as found in the
crystal structure, showing a well defined RNA-binding cleft. The deep W-shaped
cleft has two Zn-fingers at the top and two SAM molecules at the bottom. The
colorcodeoftheribbonis sameas inFig.1B. (B) StereoviewoftheZn-fingermotif
of RlmAI. (C) Stereo view of SAM binding region of an RlmAI molecule. The Fo
Fc electron density (in cyan) covering the SAM molecule (in gray) was calculated
at 2.8-Å resolution based on the phasing by protein atoms only and is displayed
at 2.0. The surrounding amino acids are in yellow.
Fig. 3. Superposition of the ErmC rRNA MTase structure (34) (silver) onto the
RlmAI structure (cyan). Despite the fact that both enzymes have superimposable
MTasedomains, theirputativeRNA-recognitiondomainspositiondifferentlyand
have different tertiary folds. The SAM molecule bound to ErmC is shown in gray,
and the SAM molecule-bound RlmA is shown in yellow.
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described for dimeric RlmB (32) is very different from that of
RlmAI (Fig. 4).
Binding of rRNA Substrate. The W-shaped putative rRNA-binding
cleft (Fig. 2A) is comprised of conserved amino acid residues from
both monomers of an asymmetric RlmAI dimer. Two Zn-fingers are
at the top and the two SAM molecules are at the bottom of the cleft.
At the bottom of the cleft, helices 1 from each monomer together
form a ridge that separates the two SAM-binding pockets. The
W-shaped cleft is lined with a positively charged electrostatic
surface suitable for interactions with polyanionic nucleic acids
(Fig. 4). The unusual asymmetric arrangement of RlmAI molecules
in its dimer appears to be functionally relevant in creating the
specific shape of the rRNA-binding cleft. The shape of the cleft
is unique and different from that of previously reported RNA-
binding proteins.
Considering the clearly identifiable rRNA binding cleft of Rl-
mAI, efforts were made to model the structure of its complex with
hairpin 35 of 23S rRNA. The relevant parts from structures of the
large ribosomal subunit of E. coli [by cryo-electron microscopy at
7.5 Å (37); PDB ID 1C2W], of Haloarcula marismortui [by x-ray at
2.4 Å (3); PDB ID 1FFK], eubacterium Deinococcus radiodurans
[by x-ray at 3.1 Å (5); PDB ID 1JZX], Thermus thermophilus [by
x-ray at 5.5 Å (38); PDB ID 1GIX], and the structure of hairpin 35
from Streptococcus pneumonia rRNA [by NMR (39); PDB ID
1MT4] were docked into the cleft of the RlmAI dimer (Fig. 4).
Manual docking of the portion of the E. coli rRNA structure
containing hairpins 33, 34, and 35 (nucleotides 692–770) (37), into
the RNA-binding cleft of RlmAI provides a unique complementary
match (Fig. 5A). In this modeled complex structure, hairpin 35 is
completely buried in the cleft. The RNA-bulge (knot) linking the
three hairpins (33, 34, and 35) sits over the Zn-finger regions of the
cleft, suggesting that the two Zn-fingers are responsible (i) for
recognition of the rRNA substrate structure and (ii) for placing the
hairpin 35 in the W-shaped cleft. This model of the rRNARlmAI
complex (Fig. 5A) is consistent with previously reported biochem-
ical studies (11) by showing that, in addition to the hairpin 35,
nucleotides from the adjacent hairpins 33 and 34 interact with
RlmAI; most of the interacting nucleotides are from hairpin 35 and
the RNA-bulge, whereas the top part of hairpin 34 is not interacting
with the RlmAI dimer. Interestingly, in this model of the protein
rRNA complex (Fig. 5A), the base of nucleotide G745 (the target
for methylation in Gram-negative bacteria) is positioned in close
proximity to the SAM-binding pocket of molecule 1. The excellent
unique fit of this rRNA fragment in the dimeric structure of RlmAI
suggests that the observed structural asymmetry of the dimer is
indeed required for unique recognition and binding of the rRNA
substrate.
As shown in Fig. 5B, the relative orientations of rRNA hairpins
33, 34, and 35 are somewhat different but related in different
ribosome structures. An important difference in the arrangements
of these hairpins is the angle between hairpins 33 and 35. This angle
appears to be critical for binding of the rRNA fragment to the
RlmAI dimer. Docking of the rRNA fragments from high-
resolution crystal structures of ribosomes [nucleotides 781 to 865
from H. marismortui (3), 704 to 784 from D. radiodurans (5), and
685 to 773 from T. thermophilus (38)] into the RNA-binding cleft
of RlmAI showed possible fits of hairpin 35 into the W-shaped
RNA-binding cleft; however, hairpin 33 develops steric hindrance
with RlmAI when the angle between the hairpins 33 and 35 is small
(Fig. 5B). RlmA enzymes do not act on 50S or 70S subunit of
ribosome (11), and it is therefore likely that the modeled (Fig. 5A)
23S rRNA fragment (37) more closely reflects its naked confor-
mation that actually binds to RlmA dimer. The two Zn-fingers of
the RlmA dimer apparently interact at the hinges between hairpins
33:35 and 34:35 and consequently define the appropriate shape of
the rRNA fragment.
Our current structure and modeling study suggests that most of
the RNAprotein interactions in this complex are asymmetric; one
monomer interacts differently with the RNA substrate than the
other. The asymmetric nature of the RNAprotein interactions may
be responsible for the unique fit of the substrate to the enzyme.
Fig. 4. Top (A) and side (B) views of the electrostatic potential surface of an E.
coli RlmAI dimer plotted by using GRASP (42). The positively charged regions are
in blue, and the negatively charged regions are in red. The cleft formed by an
RlmAI dimer is largely positively charged and proposed to bind the substrate,
hairpin 35 of bacterial 23S rRNA.
Fig. 5. (A) Stereo view of a modeled complex of RlmAI:E. coli 23S rRNA
fragment (37) containing hairpins 33, 34, and 35. The 3D structure of this rRNA
fragment complements the shape of the RlmAI cleft formed by the MTase and
Zn-binding domains. Nucleotide G745, which is methylated by RlmAI, is located
near the SAM-binding pocket of molecule 1. (B) Comparison of conformation of
the 23S rRNA fragment containing hairpins 33, 34, and 35 in three different
structures of ribosomes. The yellow arrows indicate the angles between the
domains of the rRNA fragments. (C) A schematic representation of the W-shaped
RNA-binding cleft of RlmAI, showing a proposed binding mode of hairpin 35 of
23S bacterial rRNA. The distances indicated are of E. coli RlmAI.








Docking of the rRNA substrate predicts that regions 6–8, 25,
38–52, 117–119, 138–141, 157–162, and 233–235 of molecule 1 and
6–8, 25, 38–52, 115–121, and 136–140 of molecule 2 of the RlmAI
dimer are likely to be involved in proteinRNA interactions. The
length of the polypeptide linker (amino acids 35–52) between the
two domains is 3–4 aa shorter in RlmAII than in RlmAI (Fig. 1A).
The amino acid sequences of the linker are also distinct for RlmAI
and RlmAII classes of the enzymes. This linker region of RlmA
enzymes may play a role in precise positioning of G745 (in RlmAI)
or G748 (in RlmAII) appropriately with respect to SAM for
methylation.
G745G748 Methylation. The above analysis suggests that an RlmA
dimer is required for binding of its substrate, hairpin 35 of 23S
rRNA. However, only one base of the rRNA substrate is methyl-
ated, and only one RlmA molecule from the dimer is required to
catalyze this N1-methylation. In ribosome structures, rRNA hairpin
35 interacts with the large -sheet of the ribosomal protein L22 and
adopts a complementary inverted ‘‘U’’ shape (Fig. 5B), which is
different from the unbound structure of the hairpin determined by
NMR (39). Docking of the L22-bound conformation of hairpin 35
from different ribosome structures (discussed in previous section)
shows a reasonable match between the hairpin and the ridge of the
W-shaped cleft of RlmAI; in these modeled complexes, two nucle-
otides [U480 and A844 of H. marismortui (3), U760 and A764 of D.
radiodurans (5), and A747 and A751 of T. thermophilus (38)], at
equivalent E. coli positions 747 and 751, point to two SAM-binding
pockets of the RlmAI dimer.
The RlmAI structure, together with sequence comparisons,
suggests similar W-shaped conformation of the rRNA binding cleft
and mode of binding of the rRNA fragment for both RlmAI and
RlmAII. Based on our structure and modeling studies, we speculate
that hairpin 35 adopts a shape complementary to the W-shaped
rRNA binding cleft, whether bound to RlmAI or to RlmAII, in
which nucleotides G745 and G748 point toward the two SAM-
binding sites of the enzyme, as shown schematically in Fig. 5C.
Alternatively, hairpin 35 may adopt somewhat different conforma-
tions when bound to RlmAI or RlmAII, such that either G745 (Fig.
5A) or G748 is pointed toward one SAM-binding pocket. In these
two proposed structures of the RlmArRNA complex, specific
proteinrRNA interactions (e.g., the interactions of the loop con-
necting the Zn-finger and MTase domains with rRNA hairpin 35)
would play decisive roles in proper positioning of the correct
nucleotide for N1-methylation catalysis.
Conclusion
The crystal structure of E. coli RlmAI has a well defined and
largely positively charged W-shaped RNA-binding cleft formed
by asymmetric dimerization (Fig. 4). Structural, functional, and
amino acid sequence similarities among RlmAI and RlmAII
enzymes (Fig. 1 A) suggest a common fold, as well as similar
SAM- and RNA-substrate binding modes, for both classes of
RlmA enzymes. It appears that the two Zn-binding domains are
responsible for recognition and binding of the hairpin 35 region
of 23S rRNA (Fig. 5A). Amino acid sequence comparison of
RlmAI and RlmAII and mapping of the conserved regions onto
the crystal structure of E. coli RlmAI indicate positioning of
some of the key conserved amino acid residues at putative
RNA-binding regions, at the SAM-binding pocket, and at the
dimer interface. Docking the publicly available atomic coordi-
nates for hairpin 35 of 23S rRNA and surrounding regions (3, 5,
37–39) into the cleft of RlmAI dimer shows complementary
RNAprotein structural features. This crystal structure, along
with earlier reported biochemical data, provides a basis for
detailed investigations aimed at understanding structural fea-
tures of the specific recognition of rRNA substrates, the role of
this type of Zn-finger in RNA recognition, general aspects of
RNAprotein interactions, and the mechanism of RNA meth-
ylation by RlmA enzymes.
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